CSQ Insider Trading Activity and SEC Form 4 Filings
CSQ insider trading summary
No open-market insider purchases or sales of Calamos Strategic Total Return Fund (CSQ) have been reported on SEC Form 4 in the past 12 months.
Latest CSQ insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jan 30, 2025 | Thomas E Herman | VP and CFO | Buy | $212K (11,507 @ $18.39) |
| Jan 29, 2025 | Thomas E Herman | VP and CFO | Buy | $213K (11,683 @ $18.23) |
| Dec 6, 2023 | John S. Koudounis | Vice President | Sell | $134K (9,476 @ $14.16) |
| Dec 6, 2023 | John S. Koudounis | Vice President | Sell | $25K (1,731 @ $14.18) |
| Dec 6, 2023 | John S. Koudounis | Vice President | Sell | $1K (100 @ $14.17) |
| Dec 6, 2023 | John S. Koudounis | Vice President | Sell | $13K (912 @ $14.19) |
| Dec 6, 2023 | John S. Koudounis | Vice President | Sell | $17K (1,191 @ $14.17) |
| May 24, 2022 | MetLife Investment Management, LLC | Insider | Buy | $8.0M (320,000 @ $25.00) |
| Aug 24, 2021 | MetLife Investment Management, LLC | Insider | Buy | $15.0M (600,000 @ $25.00) |
| Feb 12, 2021 | John S. Koudounis | Vice President | Buy | $42K (2,500 @ $16.75) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.